Show Summary Details
Page of

MED12 and Opitz-Kaveggia Syndrome 

MED12 and Opitz-Kaveggia Syndrome
MED12 and Opitz-Kaveggia Syndrome

Michael J. Lyons

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 February 2021

Opitz-Kaveggia syndrome is a rare cause of X-linked intellectual disability and associated anomalies in males due to a mutation in the MED12 gene located at chromosome Xq13. The MED12 gene encodes the MED12 protein which is part of the Mediator complex. Mediator is involved in transcriptional activation and repression. The clinical diagnosis of Opitz-Kaveggia syndrome can be made based on the recognition of typical clinical features including macrocephaly, tall forehead, downslanting palpebral fissures, small simple ears, constipation and/or anorectal anomalies, broad thumbs and halluces, abnormalities of the corpus callosum, intellectual disability, hypotonia, and characteristic behavior. An algorithm based on clinical features has been devised to help guide the decision to pursue molecular testing of the MED12 gene. A diagnosis of Opitz-Kaveggia syndrome can be confirmed by identification of a mutation in the MED12 gene. Most affected individuals have been found to have a recurrent p.R961W mutation which leads to protein conformation changes. A p.G958E mutation has been found to cause Opitz-Kaveggia syndrome in one family. A recurrent p.N1007S mutation in the MED12 gene causes Lujan syndrome which is a distinct disorder. A 12 base pair insertion in the MED12 gene has been associated with an increased risk for schizophrenia.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.